Cara Therapeutics | CARA - Efectivo Y Equivalentes





Efectivo Y Equivalentes Cambio Fecha
Acadia Pharmaceuticals USD 956.47M 105.02M 2026-06
Alterity Therapeutics Limited AUD 15.77M 9.56M 2023-06
Cara Therapeutics USD 19.85M 883K 2026-03
Cassava Sciences USD 86.57M 8.93M 2026-03
Chugai Pharma JPY 426.6B 29.83B 2025-12
Cipla INR 10.18B 2.22B 2026-03
Clal Biotechnology ILS 5.73M 1.71M 2023-12
Compugen USD 12.43M 78.16M 2026-03
CSL USD 2.16B 633M 2025-06
Grifols EUR 979.78M 334.84M 2024-12
Halozyme Therapeutics USD 163.14M 146.61M 2026-06
J&J USD 20.42B 1.27B 2026-06
Neurocrine Biosciences USD 332.4M 65.9M 2026-06
Pacira USD 205.88M 61.57M 2026-06
Pfizer USD 976M 727M 2026-06
RedHill Biopharma USD 2.87M 1.75M 2025-06
Supernus Pharmaceuticals USD 179.95M 4.92M 2026-06
Vanda Pharmaceuticals USD 84.85M 14.83M 2025-12